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ABSTRACT 
Antimicrobial resistance (AMR) presents a major threat 
to global public health and economic development. 
Therefore, countries were required to have an action plan 
on AMR implemented by mid-2017. The research 
objective of this thesis is to explore whether the action 
plans of nine EU member states incorporated the One 
Health approach (human and animal health and the 
environment are interlinked). Only five plans were 
identified to include the components of the One Health 
concept sufficiently. To conclude, all countries must 
develop a holistic national action plan and ensure its 
effective implementation in order to fight AMR.   
Keywords 
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INTRODUCTION 
Trends are showing an increase in incidences of 
infections resistant to multidrug therapies, presenting 
serious threats for humans, animals, and the environment 
(ECDC, 2017). The number of resulting deaths within the 
EU is estimated to increase from 25,000 persons in 2007 
up to 392,000 in 2050 unless the situation changes soon 
(European Commission, 2017a). In addition, multidrug-
resistant bacteria present a high economic burden in 
terms of healthcare expenditure and cause deficits for 
trade and the agricultural sector. In the EU alone, extra 
healthcare expenditure and productivity losses cost 
around 1.5 billion euro (European Commission, 2017a). 
Therefore, AMR also hinders the achievement of the 
Sustainable Development Goals, in particular, the third 
goal.  
  
Antimicrobial resistance is a cross-border health threat 
and is, therefore, extremely relevant for Europe and the 
globe. The prevalence of AMR is generally higher in 
Southern and Eastern European compared to Northern 
countries. These differences may be explained by 
different patterns in consumption of antibiotics, different 
practices regarding surveillance, prevention, diagnostics 
and healthcare utilisation, and the extent to which 
effective national policies are implemented (ECDC, 
2017a).  
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Member states are responsible to develop and implement 
health policies and regulations. Therefore, legally-binding 
policies and activities against AMR are still heterogeneous 
across the member states of the EU, despite frequent 
attempts to influence the political agenda and harmonise 
the response of individual countries in the fight against 
AMR. At the global level, the Global Action Plan on 
Antimicrobial Resistance by the WHO and the European 
One Health Action Plan against Antimicrobial Resistance 
by the European Commission serve as the global blueprint 
for AMR activities and both follow the One Health 
approach (European Commission, 2017).  
 
One Health, an approach embracing interlinkages between 
human health, animal health and the environment, has 
received considerable attention and is advocated on an 
international agenda. However, the evaluation of the 
concept received much less attention, as little evidence was 
collected to assess the effectiveness of the One Health 
approach, particularly in tackling AMR. Nonetheless, 
there is a common understanding that a multisectoral 
response is needed to effectively tackle antimicrobial 
resistance due to the various transmission dynamics of 
AMR.  
 
Accordingly, at the World Health Assembly in 2015, 
countries agreed to have a multisectoral national action 
plan against AMR in place before mid-2017 (WHO, 2015). 
It is crucial to monitor the countries’ commitment in order 
to timely identify gaps and to learn from best-practice 
examples. Therefore, this thesis intends: 
 
To identify national action plans against AMR within the 
EU and to discuss to what extent the action plans are 
following the One Health approach. 
 
 
THEORETICAL FRAMEWORK 
 
Definition of terms 
Microorganisms have the ability to change their genetic 
composition over time. The development of AMR, 
therefore, is a natural process that can take place when 
microorganisms change after exposure to antimicrobial 
drugs (such as antibiotics, antifungals, antivirals, 
antimalarials and anthelmintic). Misuse and overuse of 
antibiotics for people and animals, inadequate infection 
control and sanitary conditions, as well as inappropriate 
food handling, accelerate the process of the development 
of AMR (WHO, 2017). After a microorganism develops a 
resistance to certain antibiotics, the treatment of infections 
with these antibiotics becomes ineffective. Consequently, 
the risk of persisting infections and the risk of transmitting 
the infection to people and animals is increased (ECDC, 
2017a; WHO, 2017).  
 
The general objective of an action plan is to efficiently 
reach a goal within a certain timeframe. Therefore, 
milestones and a completion date should be defined while 
considering training and resources. Furthermore, an action 
plan needs to define clear actions, responsible actors, and 
targets that confirm that the step is completed. Ownership 
must be allocated in order to ensure accountability, 
facilitate more effective communication between actors 
at the national level, and information on the progress.  
 
Theoretical model 
It is generally accepted that a multi-sectoral approach is 
needed to combat AMR in an effective, efficient, and 
sustainable way. A current major focus in policies against 
AMR is addressing the intersectoral transmission 
dynamics involving animals, humans, contaminated 
food, and the environment. Figure 1 is a graphical display 
that attempts to demonstrate the One Health concept 
(One Health, n.d.). The components of the model are 
global context, culture, economics, social determinants 
of health, ecosystem, animal, human, prevention, 
detection, and response. The aim of including the One 
Health model in the analysis is to structure the results and 
determine whether the action plans are holistic. 
 
Figure 1. One Health approach 
 
METHODOLOGY 
This thesis aims to strategically identify countries with a 
national action plan against AMR using a literature 
review. Therefore, online databases of the WHO, ECDC, 
and the European Commission were searched. Eligibility 
criteria for inclusion are: 
• Title of policy documents includes the terms 
“action plan”, “strategy” or “roadmap” 
• National plan from a member state of the EU 
• Designed to combat AMR/ antibiotic resistance 
• Available in German or English 
• Current (timeline includes the year 2018) 
• Multi-sectoral (sectoral action plans are 
excluded, e.g. action plans that tackle AMR in 
the human OR veterinary sector only). 
Each admissible action plan is then examined with regard 
to 1) the overarching goal and timeframe; 2) objectives, 
actions, and targets; 3) ownership, roles, and 
responsibilities; 4) global context; 5) economics and 
resources; 6) culture; 7) Social determinants of health; 8) 
Human, animal, and ecosystem; and 9) prevention, 
detection, and response. 
 
 
RESULTS 
Main findings: National Action Plans  
In total, 60 national action plans (including duplicates) 
from 20 different countries were identified. No 
information on national action plans has been identified 
in Bulgaria, Croatia, Estonia, Hungary, Latvia, Malta, 
Slovakia, and Slovenia. After applying the exclusion 
criteria, the action plans of nine (predominantly Northern 
and Western) countries are included in this thesis: Austria 
(AT), Denmark (DK), Finland (FI), France (FR), Germany 
(DE), Ireland (IE), Spain (ES), Sweden (SE), and the 
United Kingdom (UK).  
 
General characteristics of the action plans 
Overarching goal and timeframe 
The most recent plans were released in 2018 by Austria 
and in 2017 by Denmark, Finland, and Ireland. France and 
Sweden released their strategies in 2016, Germany and 
Spain in 2015, and the United Kingdome in 2013. All nine 
national action plans mention the plan’s overarching goal, 
which was either defined to prevent the spread of AMR 
(DE, IE, ES, UK), maintain the effectiveness of antibiotics 
(FI and SE), or both (AT, DK, FR). A temporary 
framework is included in six countries: UK (2013-2018), 
Spain (2014-2018), Germany (2015-2020), Sweden (2016-
2020), Ireland (2017-2020), and Finland (2017-2021). 
Additionally, Denmark announces the evaluation of the 
action plan in 2019.  
 
Objectives, actions and targets 
In addition, all action plans include more specific goals, 
objectives, themes, priorities, or aims to achieve the goal. 
Most action plans (except DK and SE) further identify next 
steps, measures, interventions, actions, or activities. 
However, only three countries include the date of 
commencement (IE) or implementation (AT and FR) of 
each action or measure. Most of the analysed action plans 
do not include measurable targets for reducing either 
antimicrobial consumption or occurrence of AMR except 
for France.  
 
Ownership, roles and responsibilities 
In summary, all action plans specify the institutions or 
working groups that were responsible for the development 
of the action plan. Seven of the action plans (AT, FI, FR, 
DE, IE, ES, and the UK) mention the bodies that are 
responsible for the implementation and coordination of the 
national action plan in general. However, only around half 
of the action plans (AT, FI, FR, IE, and the UK) assign 
responsible bodies to each activity.  
 
One Health characteristics of the national action plan 
Global context 
Encouragingly, all nine action plans highlight the crucial 
role that the global context plays in the fight against AMR. 
Furthermore, all action plans place emphasis on 
strengthening international partnerships and collaborations 
and sharing of knowledge and best practice examples at the 
global level and at the EU-level. The governments of five 
countries highlight their role as an international leader in 
the fight against AMR (DK, FR, DE, SW, and UK).  
 
Seven countries include the 2015 Global Action Plan on 
Antimicrobial Resistance from WHO (AT, DK, FI, FR, 
DE, IE, SE). All the countries incorporate actions and 
legislation at the EU level in their action plans. The 
European One Health Action Plan from 2017 is mentioned 
by three countries (AT, DK, and IE). Each action plan 
includes data comparisons to other EU member states. 
Furthermore, the countries support the harmonisation of 
data, indicators, and monitoring systems across Europe. 
The importance of EU (co-)funded research projects and 
initiatives under the framework programmes and Horizon 
2020 are also highlighted in the national action plans 
(AT, FI, FR, DE, ES, IE, SW, and UK).  
 
Economics and resources 
In four countries, experts from the economic field were 
involved in developing the action plan (AT, FI, FR, and 
ES). The national action plans commonly highlight 
resources, such as institutions, infrastructure data, 
policies and platforms that are already in place in the 
countries, which will be used to achieve the overall goal. 
Human resources, such as health professionals or 
administrative staff, are less amplified upon. None of the 
action plans mentions whether additional staff is required 
for the implementation of the action plan although the 
training and education of physicians and nurses is an 
often-mentioned aspect.  
 
Although most national action plans describe the cost-
effectiveness of reducing AMR, only a few consider the 
financial resources that are needed for the 
implementation. France and the UK are the only 
countries that provide financial considerations for each 
planned activity. The remaining plans either included few 
and fragmented details on financing mechanisms (AT, FI, 
DE, IE, SP) or no budget considerations (DK and SE). 
 
Culture 
The national Ministry dealing with culture was involved 
in the development of three national action plans (FI, FR 
and ES). First, the nine national action plans 
acknowledge the link between AMR, inappropriate 
prescribing, and consumption of antimicrobials in the 
human and veterinary sector. Five action plans (AT, DK, 
DE, SE, and the UK) raise the issue that patients 
themselves demand prescriptions which in return 
influences the physicians to prescribe (unnecessary) 
antibiotics. Only the German strategy mentions that 
animal owners tend to influence decision-making as well. 
Two plans report on the incorrect disposal of 
antimicrobials (DE and IE); for example, in the toilet. 
Most solutions which tackle inappropriate prescribing 
and consumption do so by antimicrobial stewardship 
(AT, DE, IE, UK), awareness-raising, and education.  
 
Social determinants of health 
Social determinants of health are the conditions that 
influence and shape people’s lives. Analysing the action 
plans for each of these factors is, however, outside the 
scope of the thesis. Ministries or bodies dealing with 
social affairs were consulted in most national action plans 
(AT, FI, FR, DE, IE, and ES). As healthcare and social 
care are often intertwined, the action plans of Finland, 
Sweden, Spain and the UK, therefore, address the social 
care sphere likewise. The impacts of social determinants 
of health on antimicrobial resistance are less-often 
addressed than the consequences of AMR (DK, IE, SE, 
ES, and the UK).  
 
Human, animal, and ecosystem 
One Health action plans need to address the human, 
animal, and the ecosystem to tackle AMR. The nine 
national action plans were developed from experts in 
various sectors including the human, animal, and 
environmental sector. Furthermore, all nine plans have 
actions planned or in place involving the human and 
animal sector. Although all of them mention the 
environment as an important part in the fight against 
AMR, only six countries (AT, FI, FR, DE, IE and SE) have 
planned concrete actions in the environmental sector.  
 
Prevention, detection, and response 
Firstly, all nine action plans cover the primary prevention 
of infections in humans and animals. Hygiene measures are 
commonly mentioned, especially in the hospital 
environment. Similarly, good animal husbandry also plays 
a role in the action plan as a mean to reduce infections in 
the veterinary sector. Vaccines play an important part in all 
plans. In the Austrian plan, however, vaccines are 
mentioned only in the context of a research project.  
 
All the action plans highlight the need for better and 
cheaper diagnostics procedures and the need for 
continuously strengthening and improving national 
surveillance of antimicrobial consumption and AMR in 
both human and animals.  Rapid Diagnostic Tests are 
mentioned in seven plans (AT, FI, FR, DE, IE, ES and the 
UK). All the action plans highlight the need to expand 
students’ and professionals’ education and training. 
Antimicrobial Stewardship Programmes, an 
interdisciplinary strategy to improve rational antibiotic 
therapies in humans, are mentioned in five action plans 
(AT, FI, DE, IE, and the UK).  
 
 
CONCLUSION 
In summary, 20 countries with a national action plan or a 
similar initiative were identified on the websites of  WHO, 
ECDC, and the European Commission. This thesis 
analyses nine action plans (AT, DK, FR, IE, SE, DE, ES, 
FR, UK), which vary in their content, scope, and purpose. 
All action plans clearly state their overarching goal, 
specific objectives, and the body responsible for the 
development of the action plan. Most action plans include 
actions (except DK and SE), a timeframe (except AT, DK, 
and FR), actors responsible for the implementation (except 
DK and SE), and actors responsible for each action (except 
DK, DE, ES, SE). None of the action plans includes 
measurable targets.  
 
The One Health model proved to be useful to structure the 
results and to explore whether the action plans are holistic. 
The action plans include the global context and, to some 
extent, social and cultural determinants. To conclude, only 
five action plans are identified which cover, at least partly, 
all the components of the One Health model (AT, FI, FR, 
DE, UK).  
 
There are several limitations to this thesis. First, no 
complete picture of action plans at a European or global 
level has been established since some action plans may not 
have been identified or were excluded from the analysis. 
Second, the development of AMR is a natural and 
unpredictable process that will always accompany 
antibiotics and AMR may still occur despite a “perfectly 
holistic” action plan. Last, a policy solely reflects the plans 
and expectations of the parties responsible for its 
development; thus, there may be a divide between 
proposed actions and implementation in practice.  
 
 
Recommendations 
Antimicrobial resistance is a threat to public health, as it 
jeopardises the effectiveness of antimicrobials and, 
thereby, the achievement of the SDGs. It is important to 
ensure that national, European, and global efforts are 
aligned to diminish cross-border threats. More guidance, 
funding, and cooperation are needed, in addition to 
research efforts into the transmission dynamics between 
sectors and the role of socioeconomic and cultural factors 
as well. 
  
The EU and international actors should increase the 
pressure on the member states which have not yet 
published their multi-sectoral action plan. Measurable 
targets at the European and national level and 
mechanisms to ensure the implementation and 
continuous evaluation of the action plan are needed. The 
EU can show their added value in combating AMR by 
providing support in terms of financial and policy 
instruments to the member states.  
 
Countries need to develop a national action plan, 
continuously improve and update their action plans, and 
ensure its implementation. Environmental, cultural, and 
social sectors, as well as financial considerations, need to 
be addressed more extensively. Furthermore, measurable 
targets, a time frame, and an evaluation should be 
included. Responsible actors should be identified for 
each action, for the coordination, and for the 
implementation of the action plan. Relevant ministries 
and various stakeholder representing One Health should 
be included in the development and realisation of the 
national action plan. Furthermore, it would be beneficial 
if the policies were translated into English, which would 
enable comparisons and the sharing of best practices.  
 
The action plans of both the UK and Spain are ending in 
2018, which presents an opportunity for the development 
of an improved plan. Several tools are currently available 
which can help the member states in developing a One 
Health action plan, such as manuals and action plans 
from international organisations. In addition, best 
practice examples exist at the national level of the EU 
(e.g., FI and FR) and outside the EU, for example in 
Norway (Norwegian Ministry of Health and Care 
Services, 2015). AMR is one of the major problems in 
today’s society. National and international efforts, 
including the development and implementation of 
national action plans, are needed more than ever to stop 
the rise of AMR and ensure a safe and healthy life for the 
next generations.  
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